中新网9月20日电 国家发展和改革委员会今日在其官方网站公布《关于进一步加强药品安全信用体系建设工作的指导意见》。意见要求，建立科学规范的药品招标采购机制，建立失信行为联合惩戒机制。

Beijing September 20, the national development and reform commission today in its official website[On further strengthening drug safety credit system construction work instruction opinion].Opinion request,To establish a scientific and standardized drug bidding procurement mechanism,Establish discreditable behavior joint disciplinary mechanism.

　　意见强调，建立和完善药品行业诚信记录和市场清退制度，对采购过程中提供虚假证明文件，恶意竞标，中标后拒不签定合同，供应质量不达标药品，未按合同规定及时配送供货，向采购机构、医疗机构和个人进行贿赂和变相贿赂的，及时在网上公示并同相关部门实现数据交换，建立失信行为联合惩戒机制。

Opinion emphasize,To establish and perfect the medicine industry credit records and the market system is to repel,In the process of purchasing providing false documents,Malicious bid,After winning the bid refused to sign the contract,Supply quality is not eligible drug,Not according to the contract timely supply and distribution,Procurement agencies to/Medical organizations and individuals to bribes and disguised bribes,Timely in the online public and with relevant departments to realize data exchange,Establish discreditable behavior joint disciplinary mechanism.